Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 25 to 48 years
- People with a body mass index (BMI) below 35 (a measure of weight relative to height)
- People who have uterine fibroids (non-cancerous growths in the womb) causing symptoms such as heavy or abnormal bleeding, pelvic pain, or a feeling of pressure, and whose doctor has recommended surgery
- People whose fibroids are located within the muscle wall of the uterus, classified as FIGO types 3 to 6, confirmed by an internal ultrasound or MRI scan
- People whose largest fibroid measures 20 cm (about 8 inches) or less in diameter
- People who have been assessed as suitable for, and are scheduled to have, an abdominal myomectomy (a surgical operation to remove fibroids through an incision in the abdomen)
- People who are willing and able to sign a written consent form
Who may not be able to join:
- People whose fibroids are classified as FIGO types 0, 1, 2, 7, or 8 — these include fibroids that grow into the uterine cavity, just beneath the inner lining of the womb, on a stalk on the outer surface of the womb, in the cervix, or near the ovaries
- People with a history of pelvic inflammatory disease, peritonitis (inflammation of the abdominal lining), or a serious infection in the abdomen or pelvis
- People who have previously had surgery on the uterus
- People who have used any hormonal treatments within the 3 months before joining the trial
- People for whom the study medications (methylergometrine or carbetocin) would not be safe, including those with a known allergy to either drug, high blood pressure, heart or lung disease, a long-term hormonal or metabolic condition such as diabetes, or reduced kidney or liver function
- People at higher risk of bleeding, including those with a known bleeding disorder, those currently taking blood-thinning or anti-clotting medications, or those with low haemoglobin (a measure of red blood cells) below 10 g/dL before surgery
- People with a BMI of 35 or above
- People whose myomectomy is converted to a full uterus removal (hysterectomy) during the operation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +201091355562
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Estimated Intraoperative and Postoperative Blood Loss
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.